Literature DB >> 1066282

The metabolism of cytosine arabinoside as a predictive test for clinical response to the drug in acute myeloid leukaemia.

J F Smyth, A B Robins, C L Leese.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1066282     DOI： 10.1016/0014-2964(76)90164-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  13 in total

Review 1.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  The relationship of Ara-C metabolism in vitro to therapeutic response in acute myeloid leukaemia.

Authors:  A L Harris; D G Grahame-Smith
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 3.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

4.  Evaluation of in vitro predictive assays for acute myelocytic leukemia.

Authors:  H D Preisler
Journal:  Blut       Date:  1980-11

5.  Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter.

Authors:  Sara M Fitzgerald; Rakesh K Goyal; William R A Osborne; Jennifer D Roy; John W Wilson; R E Ferrell
Journal:  Hum Genet       Date:  2006-01-31       Impact factor: 4.132

6.  Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro.

Authors:  J A Streifel; S B Howell
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

7.  Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.

Authors:  J S Wiley; J Taupin; G P Jamieson; M Snook; W H Sawyer; L R Finch
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

8.  Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia.

Authors:  Deepika Bhatla; Robert B Gerbing; Todd A Alonzo; Heather Conner; Julie A Ross; Soheil Meshinchi; Xiaowen Zhai; Tiffany Zamzow; Parinda A Mehta; Hartmut Geiger; John Perentesis; Stella M Davies
Journal:  Br J Haematol       Date:  2008-11-22       Impact factor: 6.998

9.  Modulation of induced resistance to adriamycin in two human breast cancer cell lines with tamoxifen or perhexiline maleate.

Authors:  B J Foster; K R Grotzinger; W M McKoy; L V Rubinstein; T C Hamilton
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

10.  Cytosine arabinoside influx and nucleoside transport sites in acute leukemia.

Authors:  J S Wiley; S P Jones; W H Sawyer; A R Paterson
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.